Cannabis Bioscience International Holdings (CBIH) Enterprise Value (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Enterprise Value across 5 years of filings, most recently posting -$90.0 for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$90.0, up 83.58% year-over-year; the trailing twelve-month figure through Feb 2026 was -$90.0 (up 83.58% YoY), and the FY2025 annual result was -$12952.0, down 1615.5% from the prior year.
• Enterprise Value came in at -$90.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from -$132.0 in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$90.0 in Q1 2026 to a low of -$25655.0 in Q1 2023.
• The 5-year median for Enterprise Value is -$881.5 (2024), against an average of -$5800.4.
• Across the five-year window, Enterprise Value surged 98.6% in 2023 and sank 1615.5% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Enterprise Value stood at -$24089.0 in 2022, then soared by 98.6% to -$337.0 in 2023, then tumbled by 197.33% to -$1002.0 in 2024, then surged by 86.83% to -$132.0 in 2025, then jumped by 31.82% to -$90.0 in 2026.
• The last three Enterprise Value figures came in at -$90.0 (Q1 2026), -$132.0 (Q4 2025), and -$223.0 (Q3 2025), per Business Quant data.